tetano
Editor, Senior Moderator
Mult Scler Relat Disord
. 2021 Mar 13;51:102900.
doi: 10.1016/j.msard.2021.102900. Online ahead of print.
Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series
Nurhan Kaya Tutar[SUP] 1 [/SUP], Sami Omerhoca[SUP] 2 [/SUP], Eda Coban[SUP] 2 [/SUP], Nilufer Kale[SUP] 2 [/SUP]
Affiliations
Abstract
Background: Since March 2020, during the Coronavirus disease 2019 (COVID-19) pandemic, it has been observed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has neurological involvement with various clinical tables.
Methods: We present 3 new cases admitted to our clinic with various neurological findings which were affected by SARS-CoV-2.
Results: Imaging studies have shown that inflammatory/demyelinizing lesions appeared in different areas of the central nervous system which were accepted as an atypical demyelinating spectrum associated with Covid 19.
Conclusions: With increasing experience, it has been suggested that SARS-CoV-2 may also have a neurotrophic effect. The spectrum of neurological involvement is also expanding as the pandemic continues. These 3 cases suggest that the virus plays a role in the clinical onset of the inflammatory/demyelinating disease.
Keywords: COVID-19; Demyelinating disease; Neurological involvement.
. 2021 Mar 13;51:102900.
doi: 10.1016/j.msard.2021.102900. Online ahead of print.
Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series
Nurhan Kaya Tutar[SUP] 1 [/SUP], Sami Omerhoca[SUP] 2 [/SUP], Eda Coban[SUP] 2 [/SUP], Nilufer Kale[SUP] 2 [/SUP]
Affiliations
- PMID: 33770573
- PMCID: PMC7954770
- DOI: 10.1016/j.msard.2021.102900
Abstract
Background: Since March 2020, during the Coronavirus disease 2019 (COVID-19) pandemic, it has been observed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has neurological involvement with various clinical tables.
Methods: We present 3 new cases admitted to our clinic with various neurological findings which were affected by SARS-CoV-2.
Results: Imaging studies have shown that inflammatory/demyelinizing lesions appeared in different areas of the central nervous system which were accepted as an atypical demyelinating spectrum associated with Covid 19.
Conclusions: With increasing experience, it has been suggested that SARS-CoV-2 may also have a neurotrophic effect. The spectrum of neurological involvement is also expanding as the pandemic continues. These 3 cases suggest that the virus plays a role in the clinical onset of the inflammatory/demyelinating disease.
Keywords: COVID-19; Demyelinating disease; Neurological involvement.